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The Management of diabetes mellitus (DM) remains an enigma 
even though the symptoms of the disease had been described more 
than 3000 years ago. This is because the central therapeutic goal of 
DM therapy, euglycemia, is influenced by complex physiologic and 
pathologic processes, some of which are clearly understood, while 
others are less clear. Suboptimal glycemic control is a recognized 
risk factor for acute and chronic complications of diabetes including 
microvascular and macrovascular diseases [1-3]. The central question 
for this editorial is whether mild hepatic dysfunction could impair 
vitamin D metabolism and secondarily lead to sub-optimal glycemic 
control.
Poor glycemic control is a growing problem in patients with type 1 
(T1DM) or type 2 diabetes (T2DM) [4] despite improvements in insulin 
formulation, delivery and adjunctive therapies [5]. A high proportion 
of youth with diabetes had elevated hemoglobin A1c (HbA1c) values, 
with 17% with TIDM, and 27% of those with T2DM showing poor 
control, defined as HbA1c ≥ 9.5% [4].
Nonalcoholic fatty liver disease (NAFLD) is the most common 
form of liver dysfunction in children [6]. Even though its prevalence is 
rising in parallel with the prevalence of childhood obesity [7], its role 
in poor glycemic control in diabetes is unknown. NAFLD represents 
a spectrum of conditions characterized by macrovesicular hepatic 
steatosis and little or no exposure to alcohol [7]. The hepatic pathology 
encompasses a range from isolated fatty infiltration to steatohepatitis, 
advanced fibrosis, and cirrhosis [6]. NAFLD is the leading cause of 
elevated liver enzymes in obese youth [8]. Several studies have reported 
an association between liver dysfunction and low vitamin D levels 
[9,10], as well as liver dysfunction and poor glycemic control [11], but 
not all three disorders acting in concert.
A crucial step in the metabolism of vitamin D, the hydroxylation 
of pre-vitamin D at the 25 position, occurs in the liver. The role of 
NAFLD on this critical step in vitamin D metabolism in children and 
adolescents with diabetes has not been fully studied. Equally, the effects 
of the resultant vitamin D deficiency on glycemic control in these 
patients have also not been well described.
The role of vitamin D on glycemic control has not been fully 
studied. A study in healthy adults with normal glucose tolerance using 
the hyperglycemic clamp technique showed a positive correlation 
of 25-hydroxyvitamin D (25OHD) level with insulin sensitivity 
[12]. Extrapolation of the data suggested that increasing the serum 
concentrations of 25OHD from 25-80 nmol/L would increase 
insulin sensitivity by 60% [12], indicating that perhaps vitamin D 
supplementation offers promise as an adjunctive therapy for those with 
DM [13]. Mitri et al. [14] reported improved pancreatic β cell function 
as well as a trend toward attenuation of the rise in HbA1c levels in 
adults at high risk of T2DM who received 2000 IU of vitamin D daily 
for 16 weeks. A study in children and adolescents showed that low levels 
of 25OHD are associated with increasing insulin resistance in patients 
at risk for diabetes [15]. Another study reported that an increase in 
vitamin D levels decreased systemic inflammatory markers in patients 
with T2DM [16]. However, a recent report by the Institute of Medicine 
did not provide support for these extra-skeletal actions of vitamin D 
[17]. Equally, a recent study failed to show any strong associations of 
25OHD with either myocardial structure or function [18].
There is a high prevalence of vitamin D deficiency in patients with 
TIDM and T2DM [19,20]. This vitamin D deficiency is often attributed 
to sequestration in fat depots, lack of sun exposure, and insufficient 
intake of vitamin D containing foods. However, the effect of hepatic 
dysfunction on the critical step of hydroxylation of pre-vitamin D at 
the 25 position has not been adequately described in those with DM. 
Therefore, to achieve the goal of glycemic control in diabetes, 
euglycemia, it will be necessary to investigate beyond the conventional 
modalities of diabetes management. It will be necessary to conduct 
studies examining the roles of hepatic dysfunction and associated 
vitamin D deficiency on glycemic control in patients with diabetes 
mellitus. My colleagues and I have embarked on this mission.
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